Omel is indicated in the treatment of-
Heartburn, Any symptoms of GERD, Erosive esophagitis (both curative and maintenance therapy), Duodenal ulcer, Gastric ulcers, Reduction of risk of upper GI bleeding in critically ill patients.
Dosage & Administration:
Duodenal ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks. Gastric ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks. Erosive Reflux Esophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Esophagitis: 40 mg once daily for 8 weeks. Gastro-esophageal reflux disease: 20 mg once daily for 4 weeks, continued for further 4-8 weeks if not fully healed; 40 mg once daily has been given for 8 weeks in gastro-oesophageal reflux disease refractory to other treatment; maintenance 20 mg once daily. Acid reflux disease (long-term management), 10 mg daily increasing to 20 mg once daily if symptoms return. Acid-related dyspepsia: 10-20 mg once daily for 2-4 weeks according to response. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary. Most patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily.
Omel 20 Capsule: Each delayed release capsule contains Omeprazole BP 20 mg as enteric pellets.
Omel 40 Capsule: Each
delayed release capsule contains Omeprazole BP 40 mg as enteric pellets.